Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$436M |
| 2 |
United Therapeutics
UTHR
|
+$393M |
| 3 |
Amazon
AMZN
|
+$376M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$372M |
| 5 |
Visa
V
|
+$364M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI EAFE ETF
EFA
|
+$313M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$272M |
| 3 |
Stellantis
STLA
|
+$222M |
| 4 |
TSMC
TSM
|
+$215M |
| 5 |
Bank of America
BAC
|
+$184M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.76% |
| 2 | Consumer Discretionary | 6.77% |
| 3 | Healthcare | 6.2% |
| 4 | Financials | 5.48% |
| 5 | Communication Services | 4.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MCW
3301
DELISTED
Mister Car Wash
MCW
| $475K | ﹤0.01% |
66,660
-309,554
| -82% | -$2.19M |
|
3302
AdvanSix
ASIX
$542M
| $475K | ﹤0.01% |
20,703
+2,224
| +12% | +$55.4K |
|
|
GRAL
3303
GRAIL Inc
GRAL
$2.72B
| $474K | ﹤0.01% |
+30,872
| New | +$501K |
|
3304
Winmark
WINA
$1.2B
| $473K | ﹤0.01% |
1,342
+322
| +32% | +$115K |
|
3305
DHT Holdings
DHT
$2.99B
| $469K | ﹤0.01% |
40,554
-29,344
| -42% | -$344K |
|
|
DAWN
3306
DELISTED
Day One Biopharmaceuticals
DAWN
| $469K | ﹤0.01% |
34,005
-137,045
| -80% | -$2.01M |
|
3307
RPC Inc
RES
$1.13B
| $467K | ﹤0.01% |
74,785
+9,609
| +15% | +$67.2K |
|
3308
Life Time Group Holdings
LTH
$10.2B
| $467K | ﹤0.01% |
24,787
-9,581
| -28% | -$151K |
|
3309
Enlight Renewable Energy
ENLT
$11.3B
| $467K | ﹤0.01% |
29,311
-12,473
| -30% | -$212K |
|
3310
Hain Celestial
HAIN
$44.6M
| $466K | ﹤0.01% |
67,507
+6,449
| +11% | +$44.3K |
|
3311
Dutch Bros
BROS
$8.86B
| $466K | ﹤0.01% |
11,257
-91,471
| -89% | -$3.14M |
|
|
SAGE
3312
DELISTED
Sage Therapeutics
SAGE
| $466K | ﹤0.01% |
42,898
-293,575
| -87% | -$3.76M |
|
3313
SFL Corp
SFL
$1.61B
| $466K | ﹤0.01% |
33,550
+4,952
| +17% | +$67K |
|
3314
Zymeworks
ZYME
$1.62B
| $466K | ﹤0.01% |
54,711
+33,998
| +164% | +$303K |
|
3315
10x Genomics
TXG
$5.88B
| $466K | ﹤0.01% |
23,934
+11,395
| +91% | +$298K |
|
3316
AvePoint
AVPT
$2.76B
| $465K | ﹤0.01% |
44,598
+9,079
| +26% | +$78.7K |
|
|
CNSL
3317
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
| $464K | ﹤0.01% |
105,546
+4,439
| +4% | +$19.2K |
|
3318
Sagimet Biosciences
SGMT
$435M
| $464K | ﹤0.01% |
135,744
+130,735
| +2,610% | +$600K |
|
3319
Schwab US REIT ETF
SCHH
$11.7B
| $464K | ﹤0.01% |
23,244
+21,640
| +1,349% | +$422K |
|
3320
Rayonier
RYN
$6.67B
| $464K | ﹤0.01% |
17,581
-23,104
| -57% | -$635K |
|
3321
Astec Industries
ASTE
$1.17B
| $462K | ﹤0.01% |
15,584
-48
| -0.3% | -$1.73K |
|
3322
iShares Europe ETF
IEV
$1.64B
| $462K | ﹤0.01% |
8,429
+45
| +0.5% | +$2.51K |
|
|
NWLI
3323
DELISTED
National Western Life Group, Inc. Class A
NWLI
| $461K | ﹤0.01% |
927
+172
| +23% | +$84.4K |
|
3324
Amneal Pharmaceuticals
AMRX
$6.1B
| $460K | ﹤0.01% |
72,383
+6,254
| +9% | +$39.7K |
|
|
LADR
3325
Ladder Capital
LADR
$1.24B
| $459K | ﹤0.01% |
40,690
+5,560
| +16% | +$61K |
|
Similar funds
Citigroup's Q2 2024 Portfolio in Review
As of Q2 2024, Citigroup held 5,888 positions worth $156B, up 2.5% from $152B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Citigroup's Q2 2024 filing shows 274 new, 2,819 increased, 1,798 reduced and 330 closed positions. Its largest new stake was Ferrovial N.V. Ordinary Shares: 8,935,948 shares worth $344M. The largest sale was iShares MSCI EAFE ETF, an estimated $313M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Citigroup's largest Q2 2024 buy was Ferrovial N.V. Ordinary Shares: 8,935,948 shares worth $344M.
- Citigroup added most to Intel in Q2 2024, an estimated $436M increase.
- Citigroup's biggest Q2 2024 reduction was iShares MSCI EAFE ETF, cutting an estimated $313M.
- Citigroup fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $79.7M.
- Citigroup's ten largest holdings make up 22% of its $156B portfolio in Q2 2024.
- Citigroup opened 274 new positions and closed 330 in Q2 2024.
- Citigroup's portfolio value rose 2.5% quarter-over-quarter to $156B.
Based on Citigroup's 13F filing for Q2 2024, filed 12 Aug 2024.